Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: A Study to Assess the Effects of DPP-4 Inhibition on Insulin Sensitivity in Type 2 Diabetes [Phase 3]
A Phase 3 clinical trial update reports completion of a study evaluating the effects of a DPP-4 inhibitor on insulin sensitivity in adults w…
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: A Study to Assess the Effects of Vildagliptin on Gastric Emptying in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluated the effects of vildagliptin on gastric emptying in adults with type 2 diabetes, and the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-07Clinical Trial Update: Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Rosiglitazone in Drug Naive Patients With Type 2 Diabetes [Phase 3]
This entry notes an extension of a Phase 3 trial comparing vildagliptin to rosiglitazone in drug-naive patients with Type 2 diabetes, focusi…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Influence of Different Approaches to Dietary Advising on the Effects of Acarbose Treatment in Obese Diabetic Patients Under Real-life Setting
This completed clinical trial evaluated how different dietary counseling approaches influence the effectiveness of acarbose in obese patient…
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Inhaled Technosphere Insulin in Subjects With Diabetes Mellitus and Asthma [Phase 3]
A Phase 3 trial evaluating inhaled Technosphere Insulin in subjects with diabetes mellitus (types 1 and 2) and asthma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-04Clinical Trial Update: Glycemic Holter Study (Continuous Glucose Monitoring) - [Phase 4]
Completed Phase 4 trial evaluating continuous glucose monitoring (glycemic Holter) in Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS research · 2012-05-04Clinical Trial Update: Diabetes Mellitus Community Based Screening in Minority Populations
This clinical trial update describes a community-based screening program for type 2 diabetes mellitus in minority populations. It is sponsor…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus [Phase 2]
Phase 2 study of ITCA 650 (exenatide in the DUROS delivery system) for type 2 diabetes mellitus completed with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1) [Phase 3]
A Phase 3 trial comparing sitagliptin to glipizide in adults with type 2 diabetes mellitus and end-stage renal disease, with results posted …
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of Vildagliptin in Patients With Type 2 Diabetes [Phase 2]
Phase 2 clinical trial assessing the efficacy and safety of vildagliptin in patients with Type 2 diabetes mellitus has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients [Phase 1]
Phase 1 pharmacokinetic study of LAF237 and its metabolites in patients with mild renal impairment who have type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: A Clinical Study to Assess the Effect of Vildagliptin on Postprandial Lipid Parameters in Patients With Type 2 Diabetes [Phase 2]
This update reports the completion of a Phase 2 clinical trial evaluating the effect of vildagliptin on postprandial lipid parameters in pat…
-
CLINICAL_TRIALS trial_result · 2012-05-02Clinical Trial Update: A Clinical Study to Assess the Efficacy and Safety of Three Doses of Vildagliptin in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 trial evaluated the efficacy and safety of three doses of vildagliptin in adults with type 2 diabetes. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Effects of Short-term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Patients [NA]
This clinical trial update examines the effects of short-term intensive insulin therapy in patients newly diagnosed with type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: Evaluation of the Performance and Use of Non-Invasive Glucose Monitoring Device [Phase 1, Phase 2]
Clinical trial update on a non-invasive glucose monitoring device being tested in Phase 1 and Phase 2 for type 1 and type 2 diabetes.
-
CLINICAL_TRIALS research · 2012-05-01Clinical Trial Update: Attachment Style of Type 2 Diabetics, and Cognitive, Social and Emotional Variables as Explanatory Factors of Adherence to Self-care Behavior and Diabetes Control
A clinical trial update examining how attachment style and cognitive, social, and emotional factors relate to adherence to self-care and dia…
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Study of the Efficacy and Safety of Inhaled Technosphere Insulin in Patients With Type 2 Diabetes [Phase 2]
This Phase 2 clinical trial update reports the efficacy and safety findings of inhaled insulin for patients with Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: Use of Beta-blockers and Risk of New Onset Diabetes
The completed trial update investigates whether use of beta-blockers is associated with an increased risk of new-onset diabetes in patients …
-
EMA withdrawal · 2012-04-30EMA Application withdrawn: Pioglitazone ratiopharm (pioglitazone) — Ratiopharm GmbH
The EMA withdrawal indicates the pioglitazone application by Ratiopharm GmbH for Type 2 diabetes has been withdrawn.
-
EMA withdrawal · 2012-04-30EMA Application withdrawn: Pioglitazone ratiopharm GmbH (pioglitazone) — Ratiopharm GmbH
The EMA withdrew the application for pioglitazone (Ratiopharm GmbH) for type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2012-04-30Clinical Trial Update: 18-Week, Randomized, Double-blind, Placebo Controlled, Forced Titration Study of Patients With Type 2 Diabetes [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial in Type 2 diabetes mellitus completed after an 18-week treatment period.
-
EMA withdrawal · 2012-04-30EMA Application withdrawn: Pioglitazone ratio (pioglitazone) — Ratiopharm GmbH
The EMA has withdrawn an application for a pioglitazone ratio product by Ratiopharm GmbH, related to Type 2 diabetes.
-
FDA approval · 2012-04-27FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for LEVEMIR (insulin detemir) from Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: A Pilot Study to Evaluate the Effects of Nateglinide vs. Glibenclamide on Renal Hemodynamics and Albumin Excretion [Phase 4]
Phase 4 pilot study comparing nateglinide with glibenclamide to assess renal hemodynamics and albumin excretion in type 2 diabetes. The tria…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 3]
A Phase 3 trial evaluating BMS-298585 as monotherapy in adults with Type 2 diabetes and inadequate glycemic control has completed.